Antibody aggregation. The molecular origin of antibody aggregation and viscosity remains unc...

Apr 21, 2017 · Antibody aggregation continues to challenge the d

Aggregation may render an antibody non-functional, not to mention that some protein aggregates can also be toxic or may elicit an immune response in the patients, so that even a small fraction of ...Jan 25, 2022 · Antibody amyloidogenesis is of great concern for diseases in humans, but has limited application in the development of therapeutic proteins. 23 Moreover, a machine learning-based model that was trained on 21 mAbs was developed to predict therapeutic antibody aggregation rates at 150 mg/ml using structural-based features extracted from MD ... PMCID: PMC6698864 DOI: 10.3390/antib5030019 Monoclonal antibodies (mAbs) are the fastest-growing biological therapeutics with important applications ranging from cancers, autoimmunity diseases and metabolic disorders to emerging infectious diseases. Aggregation of mAbs continues to be a major problem in their developability. Antibody aggregat …Agglutination or aggregation involves the cross-linking of pathogens by antibodies to create large aggregates (Figure \(\PageIndex{8}\)). IgG has two Fab antigen-binding sites, which can bind to two separate pathogen cells, clumping them together. When multiple IgG antibodies are involved, large aggregates can develop; these aggregates are ...In contrast, the antibody profiling rules incorrectly identified the aggregation propensity of several samples (false positive and false negative aggregation propensity assignments). CNTO607 IgG4 had three flags, suggesting high aggregation propensity, but this antibody was reported to be stable at 110 mg/ml in PBS Citation 37 and had a high ... This paper investigates how mAb aggregates generated by a variety of mechanical, thermal and chemical stresses impact the biological activity of a biotherapeutic. Increased aggregation resulted in a decrease in biological activity, as confirmed by cell based assays such as antibody dependent cell mediated cytotoxicity (ADCC) and complement ...• The recombinant antibody aggregation in mammalian cell systems is reviewed. • Intracellular environment and extracellular parameters influence recombinant antibody aggregation. • Reducing the aggregations can improve the quality of recombinant antibodies. IntroductionIntroduction. Therapeutic antibodies are prone to form aggregates during manufacturing, handling, and storage. A combination of different patient and drug …This product is manufactured by BioVision, an Abcam company and was previously called K308 Antibody/Protein Aggregation Assay Kit. K308-100 is the same size as the 100 test size of ab234048. Antibody and protein aggregation are important issues in the field of Biotherapeutics. A wide range of conditions and different stages of processing of ...Keywords: bispecific, antibodies, aggregate removal, purification process Introduction The success of monoclonal antibody (mAb) therapeutics has driven exploration into designer biotherapeutics capable of combinatorial, more targeted approaches. A prominent example of these strategies are bispecific antibodies (BisAbs), whichOct 6, 2020 · Perfusion reduces bispecific antibody aggregation via mitigating mitochondrial dysfunction-induced glutathione oxidation and ER stress in CHO cells. Pritam Sinharoy 1, Aaron H. Aziz 1, However, the pH- and temperature-dependence of aggregation is complicated for antibody formulations. In this study, a human monoclonal IgG2 antibody exhibited typical pH-dependent dimer formation under normal storage conditions (4 and/or 29°C). However, an inversed pH-dependence was discovered for high molecular weight …Hydrophobicity has been used to predict antibody aggregation in earlier works. 13, 16 In addition, in our previous work, we also found SCM_pos is an important feature for the antibody aggregation ...For the variations in the secondary structure of the antibody during aggregation, we have monitored the Far-UV circular dichroism (CD) spectra of the same antibody solutions using a Jasco-815 CD spectrophotometer (Mary’s Court, Easton, MD) with the temperature of the cell holder controlled at 25°C. A quartz cuvette with 0.1 cm …Crosslinking antibodies selectively ‘activate’ the ADE pathway, as do environmental stresses and other molecules which facilitate aggregation of cell surface proteins. After internalisation of the aggregated cell surface proteins by the ADE pathway, the material is then degraded by lysosomes, the primary digestive unit within cells, …presence of aggregate in monoclonal antibody solutions. While the method cannot separate different forms of aggregate, it can be used as a quick screening method to identify the presence of aggregates, before using SEC analysis to separate them. The Agilent AdvanceBio SEC column, used with the Agilent 1260 Bio-LC system, proved capable of Tumor cell-induced platelet aggregation (TCIPA) is not only a recognized mechanism for paraneoplastic thrombocytosis but also a potential breakthrough alternative for a low response to immune checkpoint inhibitors (ICIs) in hematogenous metastasis of malignant melanoma (MM). ... Antibody labeling was performed using Fc-receptor blockers ...Antibody Aggregation Analysis. The percentage of antibody aggregates was determined using a standard size exclusion chromatography (HP-SEC) method. An Agilent HPLC system (Agilent 1200 series) was used with a 7.8 mm × 300 mm TSKgel G3000SW XL column (Tosoh Bioscience, 08541) at 1 mL/min flow rate using a mobile …Feb 12, 2022 · Low pH viral inactivation is a common step in antibody purification and may affect antibody re-oxidation and aggregation behavior. In this study, antibodies were reduced using the thioredoxin system and treated under low pH, and then antibodies were neutralized subsequently to determine the effect of low pH viral inactivation on aggregate ... In antibody aggregation studies, common methods include difference spectra, principal component analysis (PCA), partial least squares (PLS) and multivariate curve resolution (MCR) [22,23,40]. The application of chemometrics to Raman data is a broad area of research.Protein aggregation occurs when misfolded/unfolded proteins physically aggregate due to a series of sequential and parallel events, which may be accompanied by changes in the native …For the variations in the secondary structure of the antibody during aggregation, we have monitored the Far-UV circular dichroism (CD) spectra of the same antibody solutions using a Jasco-815 CD spectrophotometer (Mary’s Court, Easton, MD) with the temperature of the cell holder controlled at 25°C. A quartz cuvette with 0.1 cm …The drugs associated with ADCs often have less than desirable aqueous solubility characteristics themselves. These drugs have the propensity to cause inter-antibody aggregation through either exposure of protected aggregation-prone regions within the antibody backbone upon conjugation or through drug–drug mediated interactions . This …Apr 12, 2021 · This work provides valuable insight into the mechanisms of oxidative-stress induced protein aggregation, as well as strategies to minimize such aggregate formation during the development and storage of therapeutic proteins. Keywords: monoclonal antibody, free radical, protein aggregation, oxidation, excipient. 1. Self-interaction of a therapeutic monoclonal antibody may cause aggregation, high viscosity, or low solubility, which limits its likelihood of being successfully developed as a drug (i.e., the developability of the drug). 1-5 Ideally, antibodies with self-interaction tendancies could be rapidly eliminated early in the discovery stage, with minimum material consumption, …Oct 1, 2020 · Antibody aggregation also leads to low expression yield from host cells, affecting biological activity, and may increase immunogenic responses [39]. Clearly, such adverse effects must be prevented. Arosio et al. [40] reported that pH and salt concentration are among the main parameters affecting monoclonal antibody aggregation. Low pH (pH < 4.0 ... Antibody aggregation in certain solutions can occur very rapidly. High antibody concentration aggregation (>50 mg/ml) is widely known and is an important issue in antibody manufacturing and packaging for clinical or laboratory use. Low concentration antibody aggregation is generally controlled in the immunoassay environment through the use of ...This study aimed in understanding the degradation behaviors of an IgG 1 subtype therapeutic monoclonal antibody A (mAb-A) associated with pH and buffer species. The information obtained in this study can augment conventional, stability-based screening paradigms by providing the direction necessary for efficient experimental design. …Monoclonal antibodies are the fastest growing class of therapeutics. However, aggregation limits their shelf life and can lead to adverse immune responses. Assessment and optimization of the long-term antibody stability are therefore key challenges in the biologic drug development. Here, we present a platform based on the analysis of temperature-dependent aggregation data that can dramatically ...Antibody aggregation in certain solutions can occur very rapidly. High antibody concentration aggregation (>50 mg/ml) is widely known and is an important issue in antibody manufacturing and packaging for clinical or laboratory use. Low concentration antibody aggregation is generally controlled in the immunoassay environment through the use of ...Antibody aggregation could be triggered by partial unfolding of its domains, leading to monomer-monomer association followed by nucleation and growth.Therapeutic antibodies play a crucial role in the treatment of various diseases. However, the success rate of antibody drug development is low partially because of unfavourable biophysical properties of antibody drug candidates such as the high aggregation tendency, which is mainly driven by hydrophobic interactions of antibody molecules. Therefore, early screening of the risk of hydrophobic ...Protein aggregation is a major concern in biotherapeutic applications of monoclonal antibodies. Introducing charged mutations is among the promising strategies to improve aggregation resistance.The results indicate that downstream manufacturing processes should be customized for IgG 4 subclass antibodies to avoid acid-induced aggregation. Protein A chromatography is a universal mAb capture step for commercial antibody manufacturing. The use of low pH buffer for elution from rProtein A was known to contribute to aggregate production.For the variations in the secondary structure of the antibody during aggregation, we have monitored the Far-UV circular dichroism (CD) spectra of the same antibody solutions using a Jasco-815 CD spectrophotometer (Mary’s Court, Easton, MD) with the temperature of the cell holder controlled at 25°C. A quartz cuvette with 0.1 cm …Viral aggregation impacts different aspects of viral pathogenesis including infectivity, antibody escape, and antiviral resistance. Some studies have demonstrated an enhancement of viral infectivity when viruses were in an aggregated state as opposed to being in a monodispersed state [ 3 , 9 , 73 , 74 ].Protein aggregation during monoclonal antibody (mAb) production can occur in upstream and downstream processing (DSP). Current methods to determine aggregate formation during cell culture include size exclusion chromatography (SEC) with a previous affinity chromatography step in order to remove disturbing cell culture components.antibody aggregation rate during subsequent low pH virus inactivation hold. J Chromatogr A 1415, 83–90. Vazquez-Rey M and Lang DA (2011). Aggregates in monoclonal antibody manufacturing processes. Biotechnol Bioeng 108, 1,494–1,508. Aggregate Content of CHT XT Eluate (mAb S) Significant reduction of the mAb S aggregate was achievedSep 5, 2016 · In this review, we describe how the unfolding and aggregation susceptibilities of IgG could be related to their cognate sequences and structures. The impact of antibody domain structures on thermostability and aggregation propensities, and effective strategies to reduce aggregation are discussed. Oxidation is an important degradation pathway of protein drugs. The susceptibility to oxidation is a common concern for therapeutic proteins as it may impact product efficacy and patient safety. In this work, we used 2,2′-azobis (2-amidinopropane) dihydrochloride (AAPH) as an oxidative stress reagent to evaluate the oxidation of therapeutic antibodies. In addition to the …Aggregate formation is influenced by multiple aspects of the bioproduction process but can be mitigated by good process design and control. Monoclonal antibody (mAb) products have emerged as an extremely important and valuable class of therapeutic products for the treatment of cancer and other diseases such as rheumatoid arthritis, auto ...High molecular weight (HMW) aggregate formation of therapeutic monoclonal antibodies (mAbs) during cation-exchange chromatography (CEX) has been frequently observed, and can be a challenge for downstream purification. To gain mechanistic understanding of this phenomenon, aggregate formation in bind-elute CEX for two …Antibody aggregation also leads to low expression yield from host cells, affecting biological activity, and may increase immunogenic responses [39]. Clearly, such adverse effects must be prevented. Arosio et al. [40] reported that pH and salt concentration are among the main parameters affecting monoclonal antibody aggregation. Low pH (pH < 4.0 ...The supernatant postagitation was analyzed using SE-HPLC, FTIR, and AUC analyses and revealed no changes in conformation and aggregation profile when compared to the nonagitated antibody sample. The antibody particles were comprised of a combination of nonnative intermolecular disulfide-linked covalent as well as noncovalent interactions. Detecting & Removing Aggregates. Biological products such as monoclonal antibodies (mAbs) are prone to protein aggregation during production. Aggregation leads to challenges in the production environment, impacting the efficiency of purification operations. More importantly, it can lead to drug safety concerns for patients; high levels of ... Jan 1, 2020 · Overall, our results suggest that thermal stress also accelerates aggregation pathways that are not relevant for storage conditions, leading to the formation of an aggregate population that may not be representative of the aggregates formed over the shelf-life of antibody drugs. 28 Nis 2020 ... Carbohydrates tended to reduce aggregation propensity due to their preferential interactions with exposed aromatic residues. However, their ...The molecular origin of antibody aggregation and viscosity remains unclear, but hydrophobicity and charge are considered to be the two major driving forces.23,25 Recent studies that evaluated the aggregation and viscosity of 21 mAbs showed no overlap between those with high aggregation rates and thoseA host of diverse stress techniques was applied to a monoclonal antibody (IgG 2) to yield protein particles with varying attributes and morphologies.Aggregated solutions were evaluated for percent aggregation, particle counts, size distribution, morphology, changes in secondary and tertiary structure, surface hydrophobicity, metal …Protein aggregates may impact significantly the product quality, safety and/or efficacy. This review is intended to summarize four major aspects of protein aggregation – (1) aggregation mechanisms, (2) aggregation-influencing factors, (3) detection of protein aggregates, and (4) control of protein aggregation based on recent literature in ...Mar 15, 2022 · Therapeutic antibodies play a crucial role in the treatment of various diseases. However, the success rate of antibody drug development is low partially because of unfavourable biophysical properties of antibody drug candidates such as the high aggregation tendency, which is mainly driven by hydrophobic interactions of antibody molecules. Therefore, early screening of the risk of hydrophobic ... Antibody aggregate is a common issue in therapeutic antibodies, which may compromise product efficacy and cause adverse effects. Antibody aggregate level is normally controlled in bioprocessing by polishing steps after Protein A capture. This paper studied the Higher Order Structures (HOS) of antibody aggregates (dimer H1 and H2) and their ...Hydrophobicity has been used to predict antibody aggregation in earlier works. Citation 13, Citation 16 In addition, in our previous work, we also found SCM_pos is an important feature for the antibody aggregation rate. It should be noted that SCM includes a distance cutoff of 10 Å, so SCM_pos_H2 does not mean only the positive charges on the ...HA is a mineral of calcium and phosphate, and this synthetic form binds antibodies via the interaction of calcium metal affinity and phosphoryl cation exchange. This unique characteristic ensures that antibody aggregation is reduced drastically (from 60 to 0.1%) with the removal of DNA and endotoxins from antibody solutions . Therefore, HA ...Previous studies suggested that certain antibody aggregates, whose Fc regions are buried, bind Protein A resin weaker than the monomer [6, 7].Considering the fact that the bsAb under study was associated with relatively high percentage of aggregates, we suspected that incomplete binding in this case might be due to existence of bsAb …For these reasons, the removal of aggregates is a focus of downstream processing. The mAb purification procedure must effectively reduce aggregate concentration in the drug product, and processes are usually optimized to target an aggregate concentration of less than 1% for the final mAb drug product. Additionally, processes must be optimized ...• The recombinant antibody aggregation in mammalian cell systems is reviewed. • Intracellular environment and extracellular parameters inuence recombinant antibody aggregation . antibody aggregation rate during subsequent low pH virus inactivation hold. J Chromatogr A 1415, 83–90. Vazquez-Rey M and Lang DA (2011). Aggregates in monoclonal antibody manufacturing processes. Biotechnol Bioeng 108, 1,494–1,508. Aggregate Content of CHT XT Eluate (mAb S) Significant reduction of the mAb S aggregate was achievedIntroduction. Formulating monoclonal antibodies (mAbs) at high concentrations may allow delivery via subcutaneous injection, but at high concentrations these formulations may exhibit reduced stability and increased viscosity. 1 Irreversible aggregation of proteins can provoke an immune response. 2 Subcutaneous injection typically requires viscosities below …Controlling aggregation is a key to successful biopharmaceutical products. Protein-based pharmaceuticals are among the fastest growing categories of therapeutic agents in the clinic and as commercial products, and typically target high-impact areas such as various cancers, auto-immune diseases, and metabolic disorders [1,2].Although commercial scale …Sep 28, 2018 · The quality of preparations of therapeutic IgG molecules, widely used for the treatment of various diseases, should be maintained during storage and administration. Nevertheless, recent studies demonstrate that IgG aggregation is one of the most critical immunogenicity risk factors that compromises safety and efficacy of therapeutic IgG molecules in the clinical setting. During the IgG ... However, recently while purifying a bispecific antibody (bsAb) in appended IgG format, the Protein A capture step experienced low yield (i.e., ∼80%). It was found that the target bsAb started appearing in flow-through at a relatively low load density, suggesting that a portion of the expressed bsAb has compromised Protein A binding capability.The phenomenon of protein aggregation is a common issue that compromises the quality, safety, and efficacy of antibodies and can happen at different steps of the manufacturing process, including fermentation, purification, final formulation, and storage. Aggregate levels in drug substance and final drug product are a key factor when assessing ...1. Introduction. Therapeutic monoclonal antibodies (mAbs) occupy a significant portion of the biopharmaceutical market; 29 new mAbs are presently undergoing late-stage clinical trials, including human and humanised IgG1, 2 and 4 molecules, amongst others [1].Industrial-scale production of biopharmaceuticals is a challenging task; …Heterogeneity of protein content in solution can encourage protein aggregation. The most common cause of aggregation with the humanized MAb epratuzumab is the disulfide scrambling (1). IgG Subclasses and Degradation Pathways: Immunoglobulins (IgGs) represent the most abundant class of antibody in human serum. Figure 1 depicts the four IgG ...Therefore, spatial aggregation propensity (SAP) was proposed for identification of any spatial antibody regions prone to aggregation (Chennamsetty et al., 2009b). Fourteen such aggregation-prone motifs of one to seven residues in sizes were identified in IgG1s ( Chennamsetty et al., 2009a ) but use of SAP to describe protein aggregation ...The SCM score has also been used as a machine learning feature to predict antibody aggregation [9,17]. The obstacles to applying SCM are the computational cost and difficulties in model construction. Show abstract. Predicting high concentration antibody viscosity is essential for developing subcutaneous administration. Computer simulations ...ABSTRACT. Significant amounts of soluble product aggregates were observed during low-pH viral inactivation (VI) scale-up for an IgG4 monoclonal antibody (mAb IgG4-N1), while small-scale experiments in the same condition showed negligible aggregation.Antibody Aggregation Analysis. The percentage of antibody aggregates was determined using a standard size exclusion chromatography (HP-SEC) method. An Agilent HPLC system (Agilent 1200 series) was used with a 7.8 mm × 300 mm TSKgel G3000SW XL column (Tosoh Bioscience, 08541) at 1 mL/min flow rate using a mobile …Aggregate content in cell culture samples was estimated using a high-resolution size-exclusion chromatography technique, which efficiently resolved the antibody monomer and aggregates in the cell ...Histidine, a widely used buffer in monoclonal antibody (mAb) formulations, is known to reduce antibody aggregation. While experimental studies suggest a nonelectrostatic, nonstructural …Background. Protein aggregation during monoclonal antibody (mAb) production can occur in upstream and downstream processing (DSP). Current methods to determine aggregate formation during cell culture include size exclusion chromatography (SEC) with a previous affinity chromatography step in order to remove disturbing cell culture components.Sep 5, 2016 · In this review, we describe how the unfolding and aggregation susceptibilities of IgG could be related to their cognate sequences and structures. The impact of antibody domain structures on thermostability and aggregation propensities, and effective strategies to reduce aggregation are discussed. 1. Introduction. It is critical to remove aggregates during the downstream purification of monoclonal antibodies (mAbs) as they can increase the risk of an immunogenic response in patients [[1], [2], [3], [4]].Unlike other impurities, such as host cell proteins and DNA, mAb aggregates contain an Fc binding domain and are not typically …Self-interaction of a therapeutic monoclonal antibody may cause aggregation, high viscosity, or low solubility, which limits its likelihood of being successfully developed as a drug (i.e., the developability of the drug). 1-5 Ideally, antibodies with self-interaction tendancies could be rapidly eliminated early in the discovery stage, with minimum material consumption, …The nearest neighbors and support vector regression models have the best performance in terms of the errors for the validation. Overall, our machine learning models performed considerably better than other existing tools for predicting antibody aggregation rate (Fig. 2). Download : Download high-res image (502KB) Download : Download full-size imageHowever, the formulation with 100 mM Arg·Glu was more stable than the reference formulation, with Arg·Glu reducing the rate of antibody aggregation 2-fold, whilst also marginally reducing the rate of fragmentation (Table 1). This illustrates that excipients, such as Arg·Glu, can improve the stability of high concentration protein solutions .... Furthermore, antibody aggregation is highly undesirable, because it cDevelopment process of recombinant antibody drugs. Mouse mono Oct 15, 2018 · Aggregate formation was tracked by analyzing the mAbs chromatographic profiles by size-exclusion liquid chromatography coupled with diode array detection. Results indicated that the tendency to aggregate depends on the particular stress conditions and on the concentration and nature of the mAb, even though all share similar IgG1-structure. It led a $50 million funding round for vernacular news app The supernatant postagitation was analyzed using SE-HPLC, FTIR, and AUC analyses and revealed no changes in conformation and aggregation profile when compared to the nonagitated antibody sample. The antibody particles were comprised of a combination of nonnative intermolecular disulfide-linked covalent as well as noncovalent interactions. It is a function of an antibody's net charge, calculated on...

Continue Reading